Lisa Kent Abel
Nurse Practitioner, Women's Health Bellevue, WA Nurse Practitioner
NPI 1609875855 CMS profile 10539766
1231 116Th Ave Ne, Bellevue, WA 98004
General payments
$5,375
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Lisa Kent Abel of Bellevue, WA is reported in the CMS Open Payments database as having received $5,375 across 9 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Nurse Practitioner, Women's Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $107 | 1 | |
| 2024 | General | $3,167 | 5 | |
| 2023 | General | $2,101 | 3 |
Beside peers
- Lisa Kent Abel
- Nurse Practitioner, Women's Health median
- Middle half of Nurse Practitioner, Women's Health
- National median
In program year 2025, general payments to Lisa Kent Abel were reported at $107. Among 3,829 Nurse Practitioner, Women's Health profiles paid that year, the median was $124 and the middle half received between $42 and $307.
Show as a table
| Year | Lisa Kent Abel | Nurse Practitioner, Women's Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $110 | $33–$291 | $132 |
| 2022 | $0 | $122 | $40–$314 | $149 |
| 2023 | $2,101 | $131 | $40–$333 | $160 |
| 2024 | $3,167 | $123 | $43–$298 | $164 |
| 2025 | $107 | $124 | $42–$307 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 12 billing codesPaid by Medicare
$1,717
Medicare patients
21
Services billed
39
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 52% | |
| COPD | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
9 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Women's Health in Washington
Tamara Tobias
Nurse Practitioner, Women's Health · Bellevue, WA
Rachel Fidino
Nurse Practitioner, Women's Health · Kennewick, WA
Anna Alston
Nurse Practitioner, Women's Health · Seattle, WA
Kendra Johnson
Nurse Practitioner, Women's Health · Spokane Valley, WA
Fasadinah Manalo
Nurse Practitioner, Women's Health · Seattle, WA
Kenna Leis
Nurse Practitioner, Women's Health · Sunnyside, WA
Related records
Nurse Practitioner, Women's Health in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Women's Health
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.